| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/03/2014 | WO2014000857A1 Liposomes active in-vivo on neurodegenerative diseases (in particular alzheimer's disease) |
| 01/03/2014 | WO2014000803A1 Method for producing a film formulation for an edible film, and the use thereof |
| 01/03/2014 | WO2014000749A1 Entrapment of oils and immobilization of proteins using novel matrices |
| 01/03/2014 | WO2014000452A1 Traditional chinese medicine compound gel for external treatment of cancer pain and preparation method for same |
| 01/03/2014 | WO2014000144A1 Compound preparation of cefotaxime sodium and sulbactam sodium as well as preparation method and application thereof |
| 01/03/2014 | WO2012175085A8 Tobacco chewing gum formulation |
| 01/03/2014 | CA2878011A1 Fenofibrate formulation |
| 01/03/2014 | CA2877968A1 Methods and compositions for natural killer cells |
| 01/03/2014 | CA2877909A1 Stable formulations for parenteral injection of small molecule drugs |
| 01/03/2014 | CA2877901A1 Fenofibrate formulation |
| 01/03/2014 | CA2877765A1 Liposomes active in-vivo on neurodegenerative diseases (in particular alzheimer's disease) |
| 01/03/2014 | CA2877724A1 Racecadotril liquid compositions |
| 01/03/2014 | CA2877619A1 Liquid preparations of amines and organic acids stabilized by salts |
| 01/03/2014 | CA2877590A1 Angiotensin converting enzyme inhibitors for treating optic neuropathy or congenital optic atrophy |
| 01/03/2014 | CA2877536A1 Methods of using polymers |
| 01/03/2014 | CA2877444A1 Pharmaceutical composition comprising fimasartan and hydrochlorothiazide |
| 01/03/2014 | CA2877190A1 Medicament form for release of active ingredients |
| 01/03/2014 | CA2877130A1 Temperature stable vaccine formulations |
| 01/03/2014 | CA2876929A1 Racecadotril lipid compositions |
| 01/03/2014 | CA2876801A1 Injectable supersaturated acetaminophen solution for spinal administration |
| 01/03/2014 | CA2876294A1 Pharmaceutical form for extended release of active substances |
| 01/02/2014 | US20140005617 Fentanyl transdermal patch |
| 01/02/2014 | US20140005600 Drug delivery system including laminated structure |
| 01/02/2014 | US20140005266 Topical formulations for administration of omega-3 fatty acids |
| 01/02/2014 | US20140005262 Racecadotril lipid compostions |
| 01/02/2014 | US20140005261 Racecadotril liquid compositions |
| 01/02/2014 | US20140005242 Allantoin-Containing Skin Cream |
| 01/02/2014 | US20140005236 Method of inhibiting harmful microorganisms and barrier-forming composition therefor |
| 01/02/2014 | US20140005218 Sublingual and buccal film compositions |
| 01/02/2014 | US20140005204 Itraconazole compositions with improved bioavailability |
| 01/02/2014 | US20140005199 Implant for the controlled release of pharmaceutically active agents |
| 01/02/2014 | US20140005179 Oral pharmaceutical dispersion compositions |
| 01/02/2014 | US20140005171 Ophthalmic Ointment Composition Comprising a Drug, an Ointment Base and a Solubilizing/Dispersing Agent |
| 01/02/2014 | US20140005142 Method of stably treating incontinence using a bulking agent |
| 01/02/2014 | US20140005135 Stable formulations for parenteral injection of small molecule drugs |
| 01/02/2014 | US20140005106 Method for administering glp-1 molecules |
| 01/02/2014 | US20140004203 Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea |
| 01/02/2014 | US20140004202 Gamma-hydroxybutyric acid granules |
| 01/02/2014 | US20140004201 Treatment of Vascular Diseases Using Encapsulated Cells Encoding and Secreting GLP-1, or a Fragment or Variant Thereof |
| 01/02/2014 | US20140004200 Polymer compositions with bioactive agent, medical articles, and methods |
| 01/02/2014 | US20140004198 Glp-1 particles and compositions |
| 01/02/2014 | US20140004197 O/w-emulsions comprising semifluorinated alkanes |
| 01/02/2014 | US20140004196 Polyamide-amine dendrimer or derivative thereof-math1 gene nano particle and use thereof in treatment of hearing loss |
| 01/02/2014 | US20140004194 Highly stable colloid from aqueous solutions of small organic molecules |
| 01/02/2014 | US20140004193 Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome |
| 01/02/2014 | US20140004192 Pharmaceutical formulations of indibulin and uses thereof |
| 01/02/2014 | US20140004191 Misuse preventative, controlled release formulation |
| 01/02/2014 | US20140004189 Modified release pharmaceutical compositions memantine |
| 01/02/2014 | US20140004187 Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative |
| 01/02/2014 | US20140004186 Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form, a surfactant, and a statin |
| 01/02/2014 | US20140004184 Coated tablet formulations and uses thereof |
| 01/02/2014 | US20140004181 Compositions and methods for exosome targeted expression |
| 01/02/2014 | US20140004180 Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain |
| 01/02/2014 | US20140004177 Cox-2 inhibitors and related compounds, and systems and methods for delivery thereof |
| 01/02/2014 | US20140004176 Delivery of treatments transdermally for fungal infections and other indications |
| 01/02/2014 | US20140004173 Production of multivesicular liposomes |
| 01/02/2014 | US20140004172 Liposomes active in-vivo on neurodegenerative diseases |
| 01/02/2014 | US20140004171 Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator (sprm), anti-progestin, or anti-progestational agent |
| 01/02/2014 | US20140004166 Stable Emulsion for Prevention of Skin Irritation and Articles Using Same |
| 01/02/2014 | US20140004160 Orally effective methylphenidate extended release powder and aqueous suspension product |
| 01/02/2014 | US20140004157 Agent for delaying digestion and absorption of lipid |
| 01/02/2014 | US20140004052 Aerosol Formulations Comprising Formoterol Fumarate Dihydrate |
| 01/02/2014 | DE102012105528A1 Arzneiform zur Freisetzung von Wirkstoffen Dosage form for releasing active substances |
| 01/02/2014 | DE10085362B3 Verfahren zur Herstellung einer Zusammensetzung für die Geruchskontrolle oder die Freisetzung eines Agens, derartige Zusammensetzung und diese umfassender Formkörper und Verfahren zur Herstellung eines Cyclodextrin umfassenden Materials A process for preparing a composition for odor control or the release of an agent, such a composition and this comprehensive body form and method of producing a cyclodextrin material comprising |
| 01/01/2014 | EP2679243A1 Co-precipitate of one or more stilbene polyphenols and their derivatives in lamellar anionic solids, it's applications and related preparation method |
| 01/01/2014 | EP2679242A1 Adjuvant for transdermal or transmucosal administration and pharmaceutical preparation containing same |
| 01/01/2014 | EP2679231A1 Agent for treating urinary incontinence including stem cells derived from amniotic fluid |
| 01/01/2014 | EP2679227A1 Nanoparticle containing prostaglandin i2 derivative |
| 01/01/2014 | EP2679222A1 Use of oligomers of lactic acid in the treatment of gynaecological infections |
| 01/01/2014 | EP2679220A1 Controlled porous osmotic pump tablet and the preparation method thereof |
| 01/01/2014 | EP2679219A1 Method for producing finely pulverized organic compound particle |
| 01/01/2014 | EP2679218A1 Moisturising Composition |
| 01/01/2014 | EP2679217A1 Non-protein stabilized clostridial toxin pharmaceutical compositions |
| 01/01/2014 | EP2679216A1 Form of medicine for the modified release of betahistine |
| 01/01/2014 | EP2678069A1 Apparatus for the controlled release of topical nitric oxide |
| 01/01/2014 | EP2678042A2 Amphiphilic dendron-coils, micelles thereof and uses |
| 01/01/2014 | EP2678036A1 Locally acting pharmaceutical compositions which can be administered by cutaneous application |
| 01/01/2014 | EP2678029A1 Spray dried myrosinase and use to produce isothiocyanates |
| 01/01/2014 | EP2678028A2 Systems and methods for therapy of kidney disease and/or heart failure using chimeric natriuretic peptides |
| 01/01/2014 | EP2678024A1 Cutaneous pharmaceutical compositions for the local treatment of canine atopic dermatitis |
| 01/01/2014 | EP2678008A1 Nanomedicines for early nerve repair |
| 01/01/2014 | EP2678007A2 Protein nanocarriers for topical delivery |
| 01/01/2014 | EP2678006A1 Packaging of solid pharmaceutical preparations containing the active substance glyceryl trinitrate |
| 01/01/2014 | EP2678004A1 Nanocapsulation of essential oils for preventing or curing infectious diseases alone or with an antibiotic |
| 01/01/2014 | EP2678003A1 Composition comprising thylakoids for delaying the uptake of molecules |
| 01/01/2014 | EP2678002A2 Therapy for kidney disease and/or heart failure |
| 01/01/2014 | EP2678001A2 Polymer conjugated protein micelles |
| 01/01/2014 | EP2678000A1 Stabilized granules containing glyceryl trinitrate |
| 01/01/2014 | CN203370132U Rhagadia manus et pedis rolling paster |
| 01/01/2014 | CN103492016A Therapeutic methods and compositions for solid delivery |
| 01/01/2014 | CN103491976A Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
| 01/01/2014 | CN103491972A Granules in liquid dosage form |
| 01/01/2014 | CN103491957A Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins |
| 01/01/2014 | CN103491953A Pharmaceutical preparation |
| 01/01/2014 | CN103491951A Chewable vehicle for mouth absorption |
| 01/01/2014 | CN103491950A Nanomedicines for early nerve repair |
| 01/01/2014 | CN103491949A Tablet-type composition for oral administration and method for producing same |
| 01/01/2014 | CN103491948A Therapeutic compositions comprising rilpivirine hcl and tenofovir disoproxil fumarate |
| 01/01/2014 | CN103491947A Composition comprising thylakoids for delaying the uptake of molecules |
| 01/01/2014 | CN103491946A Biodegradable drug delivery compositions |